AMCP Review |
|
Welcome to the Managed Healthcare Executive post-conference review for the Academy of Managed Care Pharmacy (AMCP) 27th Annual Meeting & Expo, which was held in San Diego, CA, between April 7-10. In our post-conference series, we will highlight some of the key presentations on the important clinical, governmental and business issues that will impact managed care pharmacy. |
Highlights |
|
The explosive growth in the specialty drug sector challenges the sustainability of the U.S. health system because there are not enough loss-of-earnings offsets to cover the increases. Read more. |
|
Clinical pharmacists integrated into patient care teams have the potential to improve medication measures as well as support cost-effective medication use. Read more. |
|
Managed care pharmacists should track their performance on medication measures included in Medicare’s new Five-Star Quality Rating System to help guide improvement efforts. Read more. |
|
The incentives unfolding in both the public and private insurance markets that include providers assuming more financial risk will impact prescribing decisions for specialty pharmaceuticals. Read more. |
|
|
We welcome your feedback!
Please send your comments to:
Lisa Smith
Contributing Content Director
Managed Healthcare Executive
lisa.smith@advanstar.com |
DISCLAIMER:
This information has been independently developed and provided by the editors of Managed Healthcare Executive. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
